SI0941117T1 - Acellular pertussis vaccine with diphthriae- and tetanus-toxoids - Google Patents

Acellular pertussis vaccine with diphthriae- and tetanus-toxoids

Info

Publication number
SI0941117T1
SI0941117T1 SI9730394T SI9730394T SI0941117T1 SI 0941117 T1 SI0941117 T1 SI 0941117T1 SI 9730394 T SI9730394 T SI 9730394T SI 9730394 T SI9730394 T SI 9730394T SI 0941117 T1 SI0941117 T1 SI 0941117T1
Authority
SI
Slovenia
Prior art keywords
diphthriae
toxoids
tetanus
pertussis vaccine
acellular pertussis
Prior art date
Application number
SI9730394T
Other languages
English (en)
Slovenian (sl)
Inventor
Patrick SmithKline Beecham Biologicals FLORENT
Jean SmithKline Beecham Biologicals SA STEPHENNE
Christian SmithKline Beecham Biol. VANDECASSERIE
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of SI0941117T1 publication Critical patent/SI0941117T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SI9730394T 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids SI0941117T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition
PCT/EP1997/006180 WO1998019702A1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids
EP97950137A EP0941117B1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids

Publications (1)

Publication Number Publication Date
SI0941117T1 true SI0941117T1 (en) 2002-12-31

Family

ID=10802615

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9730394T SI0941117T1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids
SI9730706T SI1240905T1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI9730706T SI1240905T1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids

Country Status (30)

Country Link
EP (2) EP0941117B1 (zh)
JP (1) JP3980652B2 (zh)
KR (1) KR100518044B1 (zh)
CN (1) CN1130226C (zh)
AR (1) AR011509A1 (zh)
AT (2) ATE222773T1 (zh)
AU (1) AU710475B2 (zh)
BR (2) BR9712917A (zh)
CA (1) CA2271008C (zh)
CO (1) CO4910171A1 (zh)
CY (2) CY2407B1 (zh)
CZ (1) CZ295954B6 (zh)
DE (3) DE69733285T3 (zh)
DK (2) DK1240905T5 (zh)
ES (2) ES2182131T3 (zh)
GB (1) GB9623233D0 (zh)
HK (2) HK1022638A1 (zh)
HU (1) HU224126B1 (zh)
IL (1) IL129530A (zh)
LU (1) LU91183I2 (zh)
NO (2) NO320186B1 (zh)
NZ (1) NZ335384A (zh)
PL (1) PL188460B1 (zh)
PT (2) PT941117E (zh)
SA (1) SA98181128B1 (zh)
SI (2) SI0941117T1 (zh)
TR (1) TR199900979T2 (zh)
TW (1) TW471971B (zh)
WO (1) WO1998019702A1 (zh)
ZA (1) ZA979984B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (fr) * 1998-11-26 2000-05-31 Pasteur Merieux MSD Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
DK2459216T3 (da) 2009-09-02 2013-12-09 Novartis Ag Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer
ES2458355T3 (es) 2010-09-01 2014-05-05 Novartis Ag Adsorción de inmunopotenciadores sobre sales metálicas insolubles
BR112013022397A2 (pt) 2011-03-02 2017-09-26 Derek O’Hagan vacinas combinadas com doses menores de antígeno e/ou adjuvante
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
JP6345603B2 (ja) 2012-03-08 2018-06-20 ノバルティス アーゲー 追加免疫ワクチンのアジュバント化された処方物
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
US20160193322A1 (en) 2013-08-05 2016-07-07 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
AP56A (en) 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
EP1088830A3 (en) 1987-06-22 2004-04-07 Medeva Holdings B.V. Hepatitis b surface antigen particles
ATE105858T1 (de) 1987-07-17 1994-06-15 Rhein Biotech Ges Fuer Biotech Dna-moleküle, die für fmdh-kontrollabschnitte und strukturgene für ein protein mit fmdh-aktivität kodieren, sowie deren anwendung.
SG48175A1 (en) 1989-07-25 1998-04-17 Smithkline Beecham Biolog Novel antigens and method for their preparation
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
CA2136429C (en) 1992-05-23 2001-12-11 Jean Petre Combined vaccines comprising hepatitis b surface antigen and other antigens

Also Published As

Publication number Publication date
NO2006005I2 (no) 2010-04-12
ATE222773T1 (de) 2002-09-15
DE69733285T3 (de) 2010-03-25
PL188460B1 (pl) 2005-02-28
IL129530A (en) 2005-11-20
DK1240905T5 (da) 2010-01-11
CA2271008A1 (en) 1998-05-14
CZ164099A3 (cs) 1999-10-13
CA2271008C (en) 2008-07-22
DE69715031T2 (de) 2003-05-08
SI1240905T1 (en) 2005-10-31
HK1050473B (zh) 2006-03-03
TR199900979T2 (xx) 1999-07-21
NO992156D0 (no) 1999-05-04
AU710475B2 (en) 1999-09-23
EP0941117A1 (en) 1999-09-15
CN1130226C (zh) 2003-12-10
ES2240647T7 (es) 2010-03-31
CY2568B1 (en) 2008-07-02
DE69733285T2 (de) 2006-01-12
CO4910171A1 (es) 2000-04-24
AR011509A1 (es) 2000-08-30
HU224126B1 (hu) 2005-05-30
ES2240647T3 (es) 2005-10-16
IL129530A0 (en) 2000-02-29
HUP9904287A1 (hu) 2000-04-28
HK1050473A1 (en) 2003-06-27
DE122005000046I1 (de) 2005-12-29
CN1236321A (zh) 1999-11-24
GB9623233D0 (en) 1997-01-08
PL333127A1 (en) 1999-11-22
NZ335384A (en) 2000-10-27
EP1240905A1 (en) 2002-09-18
AU5319698A (en) 1998-05-29
DE69715031D1 (de) 2002-10-02
EP0941117B1 (en) 2002-08-28
HUP9904287A3 (en) 2001-05-28
KR20000053092A (ko) 2000-08-25
LU91183I2 (fr) 2005-09-20
JP3980652B2 (ja) 2007-09-26
CY2407B1 (en) 2004-09-10
BR9712917A (pt) 1999-12-07
ZA979984B (en) 1998-07-23
BRPI9712917B1 (pt) 2019-12-03
TW471971B (en) 2002-01-11
WO1998019702A1 (en) 1998-05-14
PT1240905E (pt) 2005-09-30
NO992156L (no) 1999-05-04
ATE295178T1 (de) 2005-05-15
CZ295954B6 (cs) 2005-12-14
JP2001503422A (ja) 2001-03-13
NO320186B1 (no) 2005-11-07
EP1240905B1 (en) 2005-05-11
ES2182131T3 (es) 2003-03-01
HK1022638A1 (en) 2000-08-18
PT941117E (pt) 2002-12-31
DK1240905T3 (da) 2005-07-18
DK0941117T3 (da) 2002-11-18
BRPI9712917B8 (pt) 2021-05-25
NO2006005I1 (no) 2006-05-08
DE69733285D1 (de) 2005-06-16
SA98181128B1 (ar) 2006-03-25
KR100518044B1 (ko) 2005-09-30
EP1240905B3 (en) 2009-08-26

Similar Documents

Publication Publication Date Title
CY2568B1 (en) Acellular pertussis vaccine with diphtheriae- and tetanus- toxoids
PL332633A1 (en) Vaccines
EP0958373A4 (en) Vaccines.
GB9616351D0 (en) Vaccine composition
GB9410922D0 (en) Vaccines
ZA9711565B (en) Vaccine
GB9625968D0 (en) Vaccine
GB9417880D0 (en) Vaccine
GB9609252D0 (en) Vaccines
ZA952806B (en) Vaccines
GB9419969D0 (en) Vaccine
AU715243C (en) Acellular antibordetella vaccine
GB9602617D0 (en) Vaccines
GB9614182D0 (en) Vaccines
GB9604595D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9418058D0 (en) Vaccines
ZA956796B (en) Vaccines
ZA952370B (en) Vaccines
GB9418057D0 (en) Vaccines